A month after disclosing positive top-line Phase II/III data with its compound for chronic myeloid leukemia (CML), ChemGenex Pharmaceuticals Ltd. is spinning out its efforts in diabetes and obesity in favor of the cancer push.
Read More...
[Source: Yahoo! News Search Results for testicular cancer]
Wednesday, October 31, 2007
West Coast Editor (BioWorld)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment